drugset / Trial / NCT05269121
Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections
NaSingle-groupOpen-labelTreatment
Summary
This study will test the feasibility of a regimen of intraoperative (IO) and intravenous (IV) PhageBank™ bacteriophage therapy in conjunction with a DAIR procedure to cure chronic prosthetic joint infection (PJI) without replacement of the prosthesis.
Timeline
- Start
- 2022-09
- Primary completion
- 2023-11
- Completion
- 2024-11
Outcome
Outcome not reported
Stopped (Business): “Sponsor Decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PhageBank™ | Unknown | — | Intravenous |